Our findings suggest AQP1 blockade or Aqp1 deletion as effective senotherapeutic strategy with potential of pro-angiogenic efficiency for recovery of ischemic vascular diseases such as coronary artery disease and peripheral arterial disease in older adults. The gene discussed is AQP1; the disease is coronary artery disorder.